Cargando…

Proton therapy in the treatment of hepatocellular carcinoma

Liver cancer represents one of the most common causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers. Among local therapies, evidence regarding the use of radiation therapy is growing. Proton therapy currently represents the most advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dionisi, Francesco, Scartoni, Daniele, Fracchiolla, Francesco, Giacomelli, Irene, Siniscalchi, Benedetta, Goanta, Lucia, Cianchetti, Marco, Sanguineti, Giuseppe, Brolese, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393743/ https://www.ncbi.nlm.nih.gov/pubmed/36003769 http://dx.doi.org/10.3389/fonc.2022.959552

Ejemplares similares

The role of robotic surgery for the treatment of hilar cholangiocarcinoma: A systematic review
por: Brolese, Alberto, et al.
Publicado: (2022)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors
por: Dionisi, Francesco, et al.
Publicado: (2021)

Is it beneficial to use apertures in proton radiosurgery with a scanning beam? A dosimetric comparison in neurinoma and meningioma patients
por: Righetto, Roberto, et al.
Publicado: (2021)

Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020)

Quantitative Multicomponent T2 Relaxation Showed Greater Sensitivity Than Flair Imaging to Detect Subtle Alterations at the Periphery of Lower Grade Gliomas
por: Bontempi, Pietro, et al.
Publicado: (2021)

Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram
por: Rampinelli, Vittorio, et al.
Publicado: (2023)

Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment
por: Pelizzaro, Filippo, et al.
Publicado: (2022)

Intensity Modulated Proton Therapy with Advanced Planning Techniques in a Challenging Hepatocellular Carcinoma Patient
por: Apisarnthanarax, Smith, et al.
Publicado: (2017)

The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives
por: Bláha, Pavel, et al.
Publicado: (2021)

The impact of different setup methods on the dose distribution in proton therapy for hepatocellular carcinoma
por: Takemasa, Kimihiro, et al.
Publicado: (2021)

Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma
por: Iizumi, Takashi, et al.
Publicado: (2021)

Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
por: Loap, Pierre, et al.
Publicado: (2021)

Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021)

Photodynamic and Photothermal Therapy of Hepatocellular Carcinoma
por: Fan, Zhe, et al.
Publicado: (2021)

Editorial: Modeling for Prediction of Radiation-Induced Toxicity to Improve Therapeutic Ratio in the Modern Radiation Therapy Era
por: Rancati, Tiziana, et al.
Publicado: (2021)

Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma
por: Liu, Peng, et al.
Publicado: (2020)

Textbook Outcome of Laparoscopic Microwave Ablation for Hepatocellular Carcinoma
por: Lanari, Jacopo, et al.
Publicado: (2023)

Comparative Study of Amide Proton Transfer Imaging and Intravoxel Incoherent Motion Imaging for Predicting Histologic Grade of Hepatocellular Carcinoma
por: Wu, Baolin, et al.
Publicado: (2020)

Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation
por: Li, Yinuo, et al.
Publicado: (2022)

Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature
por: Rogger, Teresa Marzia, et al.
Publicado: (2020)

In-vivo range verification analysis with in-beam PET data for patients treated with proton therapy at CNAO
por: Moglioni, Martina, et al.
Publicado: (2022)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
por: Zhu, Licheng, et al.
Publicado: (2023)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

Role of Tetraspanins in Hepatocellular Carcinoma
por: Cai, Sicheng, et al.
Publicado: (2021)

Application of Immunotherapy in Hepatocellular Carcinoma
por: Miao, Lele, et al.
Publicado: (2021)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Ketogenic Diets and Hepatocellular Carcinoma
por: Lan, Yan, et al.
Publicado: (2022)

Significance of exosomes in hepatocellular carcinoma
por: Wang, GuoYun, et al.
Publicado: (2022)

FLUKA particle therapy tool for Monte Carlo independent calculation of scanned proton and carbon ion beam therapy
por: Kozłowska, Wioletta Sandra, et al.
Publicado: (2019)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study
por: Isowa, Masahide, et al.
Publicado: (2023)

Predict Treatment Response by Magnetic Resonance Diffusion Weighted Imaging: A Preliminary Study on 46 Meningiomas Treated with Proton-Therapy
por: Feraco, Paola, et al.
Publicado: (2021)

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020)

Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
por: Rognoni, Carla, et al.
Publicado: (2022)

Proton Therapy in the Management of Hepatocellular Carcinoma
por: Kobeissi, Jana M., et al.
Publicado: (2022)

Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors
por: Vennarini, Sabina, et al.
Publicado: (2022)

How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation?
por: Pagano, Duilio, et al.
Publicado: (2022)

Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience
por: Invenizzi, Federica, et al.
Publicado: (2020)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15fq9q3voofk1kk81m6a11lgn0